title: Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboembolism" by Manuela Krause et al. (Thrombosis Research 2016, published online).
authors.affiliation: Center for Vascular Medicine and Department of Medicine III, Division of Angiology, University Hospital "Carl Gustav Carus", Fetscherstrasse 74, 01307 Dresden, Germany; Kings Thrombosis Service, Department of Hematology, Kings College London, UK. Electronic address: jan.beyer@uniklinikum-dresden.de.
authors.forename: Jan
authors.initials: J
authors.lastname: Beyer-Westendorf
mesh_terms: D000328:Adult; D000925:Anticoagulants; D017984:Enoxaparin; D006470:Hemorrhage; D006801:Humans; D009025:Morpholines; D000069552:Rivaroxaban; D013876:Thiophenes; D013927:Thrombosis; D054556:Venous Thromboembolism
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban